Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) has been given a consensus rating of “Hold” by the seven ratings firms that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and two have given a strong buy rating to the company.
Several analysts have recently issued reports on the company. Citigroup restated a “sell” rating on shares of Straumann in a research report on Wednesday, October 22nd. Morgan Stanley restated an “underweight” rating on shares of Straumann in a report on Monday, December 15th. UBS Group upgraded shares of Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th. The Goldman Sachs Group lowered shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research report on Monday, October 13th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st.
Get Our Latest Analysis on SAUHY
Straumann Stock Down 0.6%
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Further Reading
- Five stocks we like better than Straumann
- GOLD ALERT
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- The $100 Trillion AI Story No One Is Telling You
- Bombshell Exposé on China Strikes
- Do not delete, read immediately
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
